2017 Sep 8-12; Madrid, Spain. Poster 1301PD 37Ipilimumab (Yervoy) US Prescr ibing Information. Bristol-Myers Squibb Company; Revised Oct 2015. 38BMS-936558: A Multi-arm Phase I Safety Study of Nivolumab in Combination with Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab, or as Monotherapy in Subjects with Stage IIIB/IV Non- small Cell Lung Cancer (NSCLC), (Study CA209012). Bristol-Myers Squibb Company; 2016.